Work

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.

Year: 1998

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: S F Slovin, H I Scher, C R Divgi, V Reuter, G Sgouros, M Moore, K Weingard, R Pettengall, M Imbriaco, A El-Shirbiny, R Finn, J Bronstein, C Brett, D Milenic, A Dnistrian, L Shapiro, J Schlom, S M Larson

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

Awards: CANCER CHEMOTHERAPY PROGRAM PROJECT, Clinical Scholars Biomedical Research Training Program

OpenAlex ID: W1597864572

FWCI: 7.267

Cites: 29

Cited by: 66

Related to: 10